Related references
Note: Only part of the references are listed.Well-being and distress of patients with Parkinson's disease: a comparative investigation
Francesca Vescovelli et al.
INTERNATIONAL PSYCHOGERIATRICS (2019)
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
Serena Sanna et al.
NATURE GENETICS (2019)
Detecting anxiety in individuals with Parkinson disease: A systematic review
Bria Mele et al.
NEUROLOGY (2018)
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
Marie Verbanck et al.
NATURE GENETICS (2018)
Multi-trait analysis of genome-wide association summary statistics using MTAG
Patrick Turley et al.
NATURE GENETICS (2018)
The MR-Base platform supports systematic causal inference across the human phenome
Gibran Hemani et al.
ELIFE (2018)
Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study
S. H. Gage et al.
PSYCHOLOGICAL MEDICINE (2017)
On the Integrity of Functional Brain Networks in Schizophrenia, Parkinson's Disease, and Advanced Age: Evidence from Connectivity-Based Single-Subject Classification
Rachel N. Plaeschke et al.
HUMAN BRAIN MAPPING (2017)
Comorbidities with chronic physical conditions and gender profiles of illness in schizophrenia. Results from PREST, a new health dataset
Andrea Gabilondo et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2017)
A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci
Diana Chang et al.
NATURE GENETICS (2017)
The psychosis spectrum in Parkinson disease
Dominic H. Ffytche et al.
NATURE REVIEWS NEUROLOGY (2017)
Oculomotricity and Neurological Soft Signs: Can we refine the endophenotype? A study in subjects belonging to the spectrum of schizophrenia
Simona Caldani et al.
PSYCHIATRY RESEARCH (2017)
Motor System Pathology in Psychosis
Sebastian Walther et al.
CURRENT PSYCHIATRY REPORTS (2017)
Inflammatory Biomarkers and Risk of Schizophrenia A 2-Sample Mendelian Randomization Study
Fernando Pires Hartwig et al.
JAMA PSYCHIATRY (2017)
Investigating causality in associations between smoking initiation and schizophrenia using Mendelian randomization
Suzanne H. Gage et al.
SCIENTIFIC REPORTS (2017)
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
Jack Bowden et al.
GENETIC EPIDEMIOLOGY (2016)
Commentary: Two-sample Mendelian randomization: opportunities and challenges
Debbie A. Lawlor
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses
Aysu Okbay et al.
NATURE GENETICS (2016)
Embracing Complexity in Psychiatric Diagnosis, Treatment, and Research
Bruce M. Cohen
JAMA PSYCHIATRY (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
Jack Bowden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Beyond boundaries: in search of an integrative view on motor symptoms in schizophrenia
Manuel Morrens et al.
FRONTIERS IN PSYCHIATRY (2015)
A Genome-wide Association Analysis of a Broad Psychosis Phenotype Identifies Three Loci for Further Investigation
Elvira Bramon et al.
BIOLOGICAL PSYCHIATRY (2014)
A case of Parkin disease (PARK2) with schizophrenia: Evidence of regional selectivity
Tae Jung Kim et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2014)
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
George Davey Smith et al.
HUMAN MOLECULAR GENETICS (2014)
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
Jeffrey Cummings et al.
LANCET (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson's Psychosis
Uli Hacksell et al.
NEUROCHEMICAL RESEARCH (2014)
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Stephen Burgess et al.
GENETIC EPIDEMIOLOGY (2013)
Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions
Sudarshana Purkayastha et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals
Zari Dastani et al.
PLOS GENETICS (2012)
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
Georg B. Ehret et al.
NATURE (2011)
Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease
Benedicte Ballanger et al.
ARCHIVES OF NEUROLOGY (2010)
Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations
Philippe Huot et al.
MOVEMENT DISORDERS (2010)
When Does Parkinson's Disease Begin?
Carles Gaig et al.
MOVEMENT DISORDERS (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [123I]IBZM SPECT
Gisela Johanna Elisabeth Schmitt et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Re: Estimation of bias in nongenetic observational studies using Mendelian triangulation by bautista et al.
Duncan C. Thomas et al.
ANNALS OF EPIDEMIOLOGY (2007)
Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group
Bernard Ravina et al.
MOVEMENT DISORDERS (2007)
Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait
Jose J. Mateos et al.
PSYCHOPHARMACOLOGY (2007)
Hallucinations in Parkinson's disease -: Prevalence, phenomenology and risk factors
G Fénelon et al.
BRAIN (2000)
Share Paper
